Last update Nov. 20, 2022

S01EB01

Compatible

Safe substance and/or breastfeeding is the best option.

It is a parasympathomimetic cholinergic with predominantly muscarinic action that stimulates the secretion of exocrine glands. Indicated in Sjögren's xerophthalmia, in glaucoma and in the induction of miosis. Topical administration as eye drops up to 4 times daily.

At the date of the last update, we found no published data on its excretion in breast milk.

The small dose and poor plasma absorption of most topical ophthalmological preparations make it unlikely that significant amounts will transfer into breastmilk. Following ophthalmic administration of pilocarpine 4%, peak betaxolol plasma concentrations were negligible. (AEMPS 2022)

Systemic absorption should be minimized by pressing the tear duct (inner corner of the eye) with the finger for 1 to 2 minutes and administering the dose immediately after breastfeeding. (Belkin 2020, Blumen 2020, Méndez 2012)

No problems were observed in an infant of a mother treated with pilocarpine eye drops. (Lustgarten 1983)

Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs: compatible with Breastfeeding. (WHO 2002)

Alternatives

We do not have alternatives for S01EB01 since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

S01EB01 is Pilocarpine, Ophtalmic Use in ATC Code/s.

Group

S01EB01 belongs to this group or family:

Tradenames

Main tradenames from several countries containing S01EB01 in its composition:

Pharmacokinetics

Variable Value Unit
Molecular weight 208 daltons
Protein Binding 0 %
VD 2.1 l/Kg
0.76 - 1.35 hours

References

  1. AEMPS. Pilocarpina oftálmica. Ficha técnica. 2022 Full text (in our servers)
  2. Belkin A, Chen T, DeOliveria AR, Johnson SM, Ramulu PY, Buys YM; American Glaucoma Society and the Canadian Glaucoma Society.. A Practical Guide to the Pregnant and Breastfeeding Patient with Glaucoma. Ophthalmol Glaucoma. 2020 Mar - Apr;3(2):79-89. Abstract
  3. Blumen-Ohana E, Sellem E. [Pregnancy & glaucoma: SFO-SFG recommendations]. J Fr Ophtalmol. 2020 Jan;43(1):63-66. Abstract
  4. Novartis. Isopto-Carpine. Drug Summary. 2017 Full text (in our servers)
  5. Méndez-Hernández C. Uso de fármacos antiglaucomatosos durante el embarazo y lactancia. [Use of glaucoma medications during pregnancy and breastfeeding]. Arch Soc Esp Oftalmol. 2012 Dec;87(12):389-91. Abstract
  6. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Abstract Full text (link to original source) Full text (in our servers)
  7. Lustgarten JS, Podos SM. Topical timolol and the nursing mother. Arch Ophthalmol. 1983 Sep;101(9):1381-2. Abstract

Total visits

453

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM